Main > A1. CORP. INDEX. Nn-Nz > Novo Nordisk /P C2

This data is not available for free

Novo Nordisk /P C2's subsections
2000. 07.10.2000. (Indl. Enzymes)
2002. 03.15.2002. (Collaboration)
2002. 09.02.2002. (Collaboration)
2002. 12.02.2002. (Metabonomics)
2002. 12.16.2002. (Diab.)
2003. 11.18.2003. (Collaboration)
2006. 03.14.2006. (Nephrology)
2006. 03.15.2006. (Nastech Pharma.)
2007. 01.22.2007. CSO & Exec VP
2007. 02.21.2007. TransTech Pharma
2007. 03.12.2007. Backs R&D In CN
2007. 04.02.2007. Pres.
2007. 11.19.2007. (Diab.)
2008. 03.06.2008. (USA>Hq.>NJ)
2008. 05.05.2008. Donates Molecule
2008. 05.13.2008. Blood Coag.
2008. 05.15.2008. Diab.
2008. 09.18.2008. IP Acq From Neose
2009. 07.03.2009. Diab>GLP-1 EU
2009. 12.08.2009. IL-21 MAb
2010. 01.26.2010. Diab>GLP-1 USA
2012. 01.24.2012. Diab>R&D>USA
2012. 05.09.2012. VP Reg Affairs
2012. 05.22.2012. Diab>Pediatrics
2012. 06.21.2012. Diab>Semaglutide
2012. 09.24.2012. Invests in CN
2012. 09.28.2012. Haemophilia
2013. 01.04.2013. Corp. VP & Gen.
2013. 02.10.2013. Insulin Degl/Asp.
2013. 10.07. Insulin Tab.
2013. 10.16. Haemophilia A
2013. 12.23. Rare Bleeding Dis.
2014. 12.23. Diab>Obesity
2015. 08.27. Acq. Calibrium & MB2
2015. 09.07. MIT Langer Lab.
2015. 09.25. Insulin Degl
2017. 01.30. Uni. Oxford
2017. 03.27. Insulin Aspart
2017. 05.31. Hemophilia B
2018. 05.23. Diabetic Nephropathy
2018. 08.17. Acq. Ziylo Ltd
2019. 02.19. Haemophilia A USA>OK
2019. 06.20. Haemophilia A EU>OK
2019. 07.12. Haemophilia A CA>OK
2019. 09.20. Diab.>Semaglutide TABs
2020. 01.06. Diab.>insulin aspart i
2020. 01.16. CV Risk Redn.
2020. 06.11. Acq. Corvidia ..
2020. 11.06. Acq. Emisphere Tech.
2020. 12.05. Obesity>Liraglutide
2021. 06.04. Obesity>Semaglutide
2021. 11.18. Acq. Dicerna Pharma.
2021. 12.28. Acq. Dicerna Pharma.
2022. 01.17. EraCal Therapeutics
2022. 03.28. Diab-2>Semaglutide 2 m
2022. 09.01. Acq. Forma Therapeutic
2023. 08.10. Acq. InverSago Pharma
2023. 10.02. Rare DISs.>PH1>USA>OK
2023. 10.16. KBP Biosciences
2024. 03.08. USA Approval
2024. 03.25. Acq. Cardior Pharma
Novo Nordisk Biotech Fund C2
Novo Nordisk Brazil C2
Novo Nordisk Inc./P C2
Patents
Web-Site
Z - OK

Novo Nordisk /P C2's products
This section has no products